Corbus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -49 | -100 | -15,642 | |
EBITDA | 59,482 | -23,342 | -17,562 | -18,578 |
EBIT | 59,663 | -17,662 | -18,659 | |
Net Income | -20,555 | -23,342 | -17,662 | -16,978 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,928 | -15,550 | -16,599 | -16,421 |
Cash | 28,492 | 26,983 | 20,044 | 18,900 |
Basic Shares | 13,317 | 12,307 | 12,240 | 12,202 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -233 | -600 | -31,167 | -1,487 |
EBITDA | -85,077 | -37,737 | -40,105 | -38,726 |
EBIT | -85,310 | -38,337 | -40,746 | -40,214 |
Net Income | -78,537 | -40,209 | -44,604 | -55,833 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -64,498 | -41,794 | -36,100 | -37,557 |
Cash | 28,492 | 17,198 | 13,724 | 17,002 |
Basic Shares | 13,317 | 10,915 | 4,327 | 4,170 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.25 |
2025-09-30 | -$1.90 |
2025-06-30 | -$1.44 |
2025-03-31 | -$1.39 |
